Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
Context: Standard-essential patent (SEP) holders increasingly expect to get paid not not only by device makers but also by streaming services. Two top-notch pool administrators have recently launched
, the UK, and with the UPC. In a ruling of September 2024, the Munich Regional court found that Amazon infringed one of Nokia’s patents. JUVE Patent does not yet know if the parties will appeal today’s
argued there was a risk of imminent infringement of its patent EP 1 830 843 B1, which protects the use of nintedanib or nintedanib esylate, from 12 December 2024. The pharma company also owns the related
The settlement had been hinted at in recent days after signs emerged in the US and at the UPC that hearings were no longer taking place. JUVE Patent learned from lawyers involved in the case that the
Apple's patent rights in smartwatch designs. But the jury awarded the tech giant, which is worth about $3.5 trillion, just $250 in damages - the statutory minimum for infringement in the United States.
we sent a Japanese lawyer to the Tokyo District Court in order to get access to the case file of what is the highest-profile patent litigation in the history of the video games industry (April 18
Context: French pharma giant Sanofi and its rival Amgen have been embroiled in patent infringement litigation over their respective cholesterol-lowering drugs, Praluent and Repatha, for over 10 years
A long-running dispute between Fresenius Medical Care and Nipro over dialysis technology has concluded in Germany. The Federal Court of Justice declared the patent-in-suit invalid, thereby removing
In the pan-European dispute over Soliris, Alexion has now suffered another defeat. The UK High Court found that an important patent relating to the active ingredient eculizumab would have to be
at the Mannheim local division concerns EP 2 028 981, the patent-in-suit at the Paris local division is EP 3 155 936. Both relate to a juice extractor. In March, the Mannheim division found that NUC
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
